Abstract
Background: The CRISPR/Cas12a and CRISPR/Cas13d systems are widely used for fundamental research and hold great potential for future clinical applications. However, the short half-life of guide RNAs (gRNAs), particularly free gRNAs without Cas nuclease binding, limits their editing efficiency and durability. Results: Here, we engineer circular free gRNAs (cgRNAs) to increase their stability, and thus availability for Cas12a and Cas13d processing and loading, to boost editing. cgRNAs increases the efficiency of Cas12a-based transcription activators and genomic DNA cleavage by approximately 2.1- to 40.2-fold for single gene editing and 1.7- to 2.1-fold for multiplexed gene editing than their linear counterparts, without compromising specificity, across multiple sites and cell lines. Similarly, the RNA interference efficiency of Cas13d is increased by around 1.8-fold. In in vivo mouse liver, cgRNAs are more potent in activating gene expression and cleaving genomic DNA. Conclusions: CgRNAs enable more efficient programmable DNA and RNA editing for Cas12a and Cas13d with broad applicability for fundamental research and gene therapy.
Funding Information
  • National Natural Science Foundation of China (82070002, 82072329, 82102443, 82200072)
  • Guangdong Basic and Applied Basic Research Foundation (2021A1515110878, 2021B1515140031)
  • Fellowship of China Postdoctoral Science Foundation (2021M701634, 2021M691473, 2022T150300)
  • National Key R&D Program of China (2022YFA0806300, 2022YFA0806300)
  • Guangdong Basic and Applied Basic Research Foundation (2023A1515012269, 2022A1515011091, 2022A1515111046)

This publication has 51 references indexed in Scilit: